Skip to main content
. Author manuscript; available in PMC: 2018 Oct 1.
Published in final edited form as: J Eur Acad Dermatol Venereol. 2017 Jun 1;31(10):1674–1680. doi: 10.1111/jdv.14310

Table 2.

Treatment Characteristics of Patients with Moderate-Severe Psoriasis

Treatment N1 (%)
Any 12,694
Phototherapy
  Any 3,329 (26.22)
  UVA/UVB 2,395 (18.87)
  PUVA 934 (7.36)
Oral systemic
  Any 9,984 (78.65)
  Methotrexate 8,796 (69.29)
  Cyclosporine 1,315 (10.36)
  Oral Retinoids 778 (6.13)
Biologic
  Any 121 (0.95)
  Etanercept 47 (0.37)
  Adalimumab 60 (0.47)
  Infliximab 14 (0.11)
  Ustekinumab 2 (0.02)
1

All treatments reported for any patient are included